Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1952 1
1953 1
1954 2
1957 1
1958 1
1959 1
1960 1
1961 2
1964 3
1965 2
1966 5
1967 6
1968 7
1969 3
1970 7
1971 2
1972 9
1973 4
1974 4
1975 1
1976 2
1977 1
1978 1
1979 2
1981 2
1982 1
1983 3
1984 1
1986 1
1987 6
1988 9
1989 6
1990 6
1991 6
1992 2
1993 5
1994 2
1995 5
1996 6
1997 4
1998 3
1999 2
2000 1
2001 2
2002 5
2003 1
2004 4
2005 9
2006 6
2007 13
2008 10
2009 10
2010 14
2011 11
2012 11
2013 11
2014 13
2015 16
2016 16
2017 19
2018 22
2019 26
2020 17
2021 21
2022 20
Text availability
Article attribute
Article type
Publication date

Search Results

374 results
Results by year
Filters applied: . Clear all
Page 1
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.
Prockop S, Doubrovina E, Suser S, Heller G, Barker J, Dahi P, Perales MA, Papadopoulos E, Sauter C, Castro-Malaspina H, Boulad F, Curran KJ, Giralt S, Gyurkocza B, Hsu KC, Jakubowski A, Hanash AM, Kernan NA, Kobos R, Koehne G, Landau H, Ponce D, Spitzer B, Young JW, Behr G, Dunphy M, Haque S, Teruya-Feldstein J, Arcila M, Moung C, Hsu S, Hasan A, O'Reilly RJ. Prockop S, et al. Among authors: jakubowski a. J Clin Invest. 2020 Feb 3;130(2):733-747. doi: 10.1172/JCI121127. J Clin Invest. 2020. PMID: 31689242 Free PMC article. Clinical Trial.
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant.
Bewersdorf JP, Derkach A, Gowda L, Menghrajani K, DeWolf S, Ruiz JD, Ponce DM, Shaffer BC, Tamari R, Young JW, Jakubowski AA, Gyurkocza B, Chan A, Xiao W, Glass J, King AC, Cai SF, Daniyan A, Famulare C, Cuello BM, Podoltsev NA, Roshal M, Giralt S, Perales MA, Seropian S, Cho C, Zeidan AM, Prebet T, Stein EM, Tallman MS, Goldberg AD, Stahl M. Bewersdorf JP, et al. Among authors: jakubowski aa. Leuk Lymphoma. 2021 Dec;62(14):3394-3401. doi: 10.1080/10428194.2021.1966788. Epub 2021 Sep 3. Leuk Lymphoma. 2021. PMID: 34477024 Free PMC article.
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.
Stuver R, Shah GL, Korde NS, Roeker LE, Mato AR, Batlevi CL, Chung DJ, Doddi S, Falchi L, Gyurkocza B, Hamilton A, Lin YH, Jakubowski AA, Joffe E, Landau HL, Lin RJ, Mailankody S, Palomba ML, Park JH, Perales MA, Ponce DM, Ramanathan LV, Salles GA, Scordo M, Seo SK, Shah UA, Stein EM, Straus D, Usmani SZ, Young JW, Zelenetz AD, Noy A, Vardhana SA. Stuver R, et al. Among authors: jakubowski aa. Cancer Cell. 2022 Jun 13;40(6):590-591. doi: 10.1016/j.ccell.2022.05.007. Epub 2022 May 16. Cancer Cell. 2022. PMID: 35598602 Free PMC article. No abstract available.
Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.
Taur Y, Coyte K, Schluter J, Robilotti E, Figueroa C, Gjonbalaj M, Littmann ER, Ling L, Miller L, Gyaltshen Y, Fontana E, Morjaria S, Gyurkocza B, Perales MA, Castro-Malaspina H, Tamari R, Ponce D, Koehne G, Barker J, Jakubowski A, Papadopoulos E, Dahi P, Sauter C, Shaffer B, Young JW, Peled J, Meagher RC, Jenq RR, van den Brink MRM, Giralt SA, Pamer EG, Xavier JB. Taur Y, et al. Among authors: jakubowski a. Sci Transl Med. 2018 Sep 26;10(460):eaap9489. doi: 10.1126/scitranslmed.aap9489. Sci Transl Med. 2018. PMID: 30257956 Free PMC article. Clinical Trial.
Letter in Reply.
Jakubowski A, Fox A. Jakubowski A, et al. J Addict Med. 2021 Jan-Feb 01;15(1):88-89. doi: 10.1097/ADM.0000000000000692. J Addict Med. 2021. PMID: 32657956 No abstract available.
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience.
Lin A, Maloy M, Su Y, Bhatt V, DeRespiris L, Griffin M, Lau C, Proli A, Barker J, Shaffer B, Giralt SA, Jakubowski AA, Papadopoulos EB, Papanicolaou GA, Seo SK, Perales MA. Lin A, et al. Among authors: jakubowski aa. Transpl Infect Dis. 2019 Dec;21(6):e13187. doi: 10.1111/tid.13187. Epub 2019 Oct 21. Transpl Infect Dis. 2019. PMID: 31585500 Free PMC article.
Defining Low-threshold Buprenorphine Treatment.
Jakubowski A, Fox A. Jakubowski A, et al. J Addict Med. 2020 Mar/Apr;14(2):95-98. doi: 10.1097/ADM.0000000000000555. J Addict Med. 2020. PMID: 31567596 Free PMC article.
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy.
Zuanelli Brambilla C, Lobaugh SM, Ruiz JD, Dahi PB, Goldberg AD, Young JW, Gyurkocza B, Shaffer BC, Ponce DM, Tamari R, Sanchez Escamilla M, Castillo Flores N, Politikos I, Scordo M, Shah GL, Cho C, Lin RJ, Maloy MA, Devlin SM, Jakubowski AA, Berman E, Stein EM, Papadopoulos EB, Perales MA, Tallman MS, Giralt SA, Smith M. Zuanelli Brambilla C, et al. Among authors: jakubowski aa. Transplant Cell Ther. 2021 Sep;27(9):771.e1-771.e10. doi: 10.1016/j.jtct.2021.05.011. Epub 2021 May 24. Transplant Cell Ther. 2021. PMID: 34033977 Free PMC article.
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation.
Lakkaraja M, Scordo M, Mauguen A, Cho C, Devlin S, Ruiz JD, Klein E, Avecilla ST, Boulad F, Cancio MI, Curran KJ, Jakubowski AA, Kernan NA, Kung AL, O'Reilly RJ, Papadopoulos EB, Prockop S, van Roessel I, Scaradavou A, Shaffer BC, Shah G, Spitzer B, Tamari R, Giralt SA, Perales MA, Boelens JJ. Lakkaraja M, et al. Among authors: jakubowski aa. Blood Adv. 2022 Feb 8;6(3):1054-1063. doi: 10.1182/bloodadvances.2021005584. Blood Adv. 2022. PMID: 34788361 Free PMC article.
374 results